| Pack Size | Price | Quantity | Add To Cart |
|---|---|---|---|
| 1 Injection/s | AUD $44.48 (44.48 / Unit) | Add To Cart | |
| 2 Injection/s | AUD $83.40 (41.70 / Unit) | Add To Cart | |
| 3 Injection/s | AUD $118.15 (39.38 / Unit) | Add To Cart |
| Active-Ingredient | Gemcitabine |
|---|---|
| Indication | Ovarian cancer, Head and neck cancer, Cervical cancer |
| Manufacturers | Fresenius Kabi India Pvt.Ltd. |
| Packaging | 1 Injection in 1 vial |
| Strength | 200mg |
| Drug Class | Antimetabolite / Nucleoside Metabolic Inhibitor |
| Dosage Form | Injection (Lyophilized Powder for Solution or Concentrate) |
| Delivery-Time | 6 To 15 days |
No key features available.
Medical Reviewer (Pharm D)
✔ Medically Reviewed • Updated: 06/03/2026
Education: Graduate Diploma in Clinical Practice - University of Sydney,
Clinical Pharmacist (Pharm D) Doctor of Medicine (MD) – University of Melbourne Biomedical Engineering – Monash University Graduate Diploma in Clinical Practice - University of Sydney, Arjun Srivastav is a dedicated Clinical Pharmacologist and the E-commerce Operations Manager at AustraliaRxMeds. With a Doctor of Pharmacy (Pharm D) and over 10 years of clinical experience at prestigious institutions like Wockhardt and Apollo Hospitals, Arjun specializes in drug safety, digital healthcare accessibility,...
Read more